Coxsackie- and adenovirus receptor (CAR) is expressed in lymphatic vessels in human skin and affects lymphatic endothelial cell function in vitro

Experimental Cell Research

Volumn 315, Issue 2, 2009, Pages 336-347

  Vigl, Benjamin ^a   Zgraggen, Claudia ^a   Rehman, Nadia ^a   Banziger Tobler, Nadia E ^a   Detmar, Michael ^a   Halin, Cornelia ^a  

^a ETH ZURICH   (Switzerland)

Author keywords

Cell adhesion; Cell migration; Coxsackie and adenovirus receptor; Lymphatic endothelial cells; Lymphatic vessels in the skin; Tube formation

Indexed keywords

COXSACKIE VIRUS AND ADENOVIRUS RECEPTOR; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BLOOD VESSEL PERMEABILITY; CELL ADHESION; CELL INTERACTION; CELL MIGRATION; CELL PROLIFERATION; COMPARATIVE STUDY; CONTROLLED STUDY; ENDOTHELIUM CELL; GENE EXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; LYMPH VESSEL ENDOTHELIUM; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKIN; VASCULAR ENDOTHELIUM;

ADENOVIRIDAE;

EID: 57749178164     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2008.10.020     Document Type: Article

References (50)

1. Alitalo K., Tammela T., and Petrova T.V. Lymphangiogenesis in development and human disease. Nature 438 (2005) 946-953
2. Jurisic G., and Detmar M. Lymphatic endothelium in health and disease. Cell Tissue Res. (2008)
3. Folkman J. Angiogenesis. Annu. Rev. Med. 57 (2006) 1-18
4. Karpanen T., and Alitalo K. Molecular biology and pathology of lymphangiogenesis. Annu. Rev. Pathol. 3 (2008) 367-397
5. Tobler N.E., and Detmar M. Tumor and lymph node lymphangiogenesis-impact on cancer metastasis. J. Leukoc. Biol. 80 (2006) 691-696
6. Wigle J.T., and Oliver G. Prox1 function is required for the development of the murine lymphatic system. Cell 98 (1999) 769-778
7. Banerji S., Ni J., Wang S.X., Clasper S., Su J., Tammi R., Jones M., and Jackson D.G. LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan. J. Cell Biol. 144 (1999) 789-801
8. Breiteneder-Geleff S., Soleiman A., Kowalski H., Horvat R., Amann G., Kriehuber E., Diem K., Weninger W., Tschachler E., Alitalo K., and Kerjaschki D. Angiosarcomas express mixed endothelial phenotypes of blood and lymphatic capillaries: podoplanin as a specific marker for lymphatic endothelium. Am. J. Pathol. 154 (1999) 385-394
9. Cueni L.N., and Detmar M. New insights into the molecular control of the lymphatic vascular system and its role in disease. J. Invest. Dermatol. 126 (2006) 2167-2177
10. Coyne C.B., and Bergelson J.M. CAR: a virus receptor within the tight junction. Adv. Drug Deliv. Rev. 57 (2005) 869-882
11. Cohen C.J., Shieh J.T., Pickles R.J., Okegawa T., Hsieh J.T., and Bergelson J.M. The coxsackievirus and adenovirus receptor is a transmembrane component of the tight junction. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 15191-15196
12. Philipson L., and Pettersson R.F. The coxsackie-adenovirus receptor-a new receptor in the immunoglobulin family involved in cell adhesion. Curr. Top. Microbiol. Immunol. 273 (2004) 87-111
13. Okegawa T., Li Y., Pong R.C., Bergelson J.M., Zhou J., and Hsieh J.T. The dual impact of coxsackie and adenovirus receptor expression on human prostate cancer gene therapy. Cancer Res. 60 (2000) 5031-5036
14. Okegawa T., Pong R.C., Li Y., Bergelson J.M., Sagalowsky A.I., and Hsieh J.T. The mechanism of the growth-inhibitory effect of coxsackie and adenovirus receptor (CAR) on human bladder cancer: a functional analysis of car protein structure. Cancer Res. 61 (2001) 6592-6600
15. Kim M., Sumerel L.A., Belousova N., Lyons G.R., Carey D.E., Krasnykh V., and Douglas J.T. The coxsackievirus and adenovirus receptor acts as a tumour suppressor in malignant glioma cells. Br. J. Cancer 88 (2003) 1411-1416
16. Excoffon K.J., Hruska-Hageman A., Klotz M., Traver G.L., and Zabner J. A role for the PDZ-binding domain of the coxsackie B virus and adenovirus receptor (CAR) in cell adhesion and growth. J. Cell. Sci. 117 (2004) 4401-4409
17. Zen K., Liu Y., McCall I.C., Wu T., Lee W., Babbin B.A., Nusrat A., and Parkos C.A. Neutrophil migration across tight junctions is mediated by adhesive interactions between epithelial coxsackie and adenovirus receptor and a junctional adhesion molecule-like protein on neutrophils. Mol. Biol. Cell 16 (2005) 2694-2703
18. Dorner A.A., Wegmann F., Butz S., Wolburg-Buchholz K., Wolburg H., Mack A., Nasdala I., August B., Westermann J., Rathjen F.G., and Vestweber D. Coxsackievirus-adenovirus receptor (CAR) is essential for early embryonic cardiac development. J. Cell Sci. 118 (2005) 3509-3521
19. Kashimura T., Kodama M., Hotta Y., Hosoya J., Yoshida K., Ozawa T., Watanabe R., Okura Y., Kato K., Hanawa H., Kuwano R., and Aizawa Y. Spatiotemporal changes of coxsackievirus and adenovirus receptor in rat hearts during postnatal development and in cultured cardiomyocytes of neonatal rat. Virchows Arch. 444 (2004) 283-292
20. Tomko R.P., Johansson C.B., Totrov M., Abagyan R., Frisen J., and Philipson L. Expression of the adenovirus receptor and its interaction with the fiber knob. Exp. Cell Res. 255 (2000) 47-55
21. Raschperger E., Thyberg J., Pettersson S., Philipson L., Fuxe J., and Pettersson R.F. The coxsackie- and adenovirus receptor (CAR) is an in vivo marker for epithelial tight junctions, with a potential role in regulating permeability and tissue homeostasis. Exp. Cell Res. 312 (2006) 1566-1580
22. Kanerva A., and Hemminki A. Modified adenoviruses for cancer gene therapy. Int. J. Cancer 110 (2004) 475-480
23. Bruning A., and Runnebaum I.B. The coxsackie adenovirus receptor inhibits cancer cell migration. Exp. Cell Res. 298 (2004) 624-631
24. Matsumoto K., Shariat S.F., Ayala G.E., Rauen K.A., and Lerner S.P. Loss of coxsackie and adenovirus receptor expression is associated with features of aggressive bladder cancer. Urology 66 (2005) 441-446
25. Dejana E. Endothelial cell-cell junctions: happy together. Nat. Rev. Mol. Cell Biol. 5 (2004) 261-270
26. Carson S.D., Hobbs J.T., Tracy S.M., and Chapman N.M. Expression of the coxsackievirus and adenovirus receptor in cultured human umbilical vein endothelial cells: regulation in response to cell density. J. Virol. 73 (1999) 7077-7079
27. Vincent T., Pettersson R.F., Crystal R.G., and Leopold P.L. Cytokine-mediated downregulation of coxsackievirus-adenovirus receptor in endothelial cells. J. Virol. 78 (2004) 8047-8058
28. Zanone M.M., Favaro E., Ferioli E., Huang G.C., Klein N.J., Perin P.C., Peakman M., Conaldi P.G., and Camussi G. Human pancreatic islet endothelial cells express coxsackievirus and adenovirus receptor and are activated by coxsackie B virus infection. FASEB J. 21 (2007) 3308-3317
29. Noutsias M., Fechner H., de Jonge H., Wang X., Dekkers D., Houtsmuller A.B., Pauschinger M., Bergelson J., Warraich R., Yacoub M., Hetzer R., Lamers J., Schultheiss H.P., and Poller W. Human coxsackie-adenovirus receptor is colocalized with integrins alpha(v)beta(3) and alpha(v)beta(5) on the cardiomyocyte sarcolemma and upregulated in dilated cardiomyopathy: implications for cardiotropic viral infections. Circulation 104 (2001) 275-280
30. Hirakawa S., Hong Y.K., Harvey N., Schacht V., Matsuda K., Libermann T., and Detmar M. Identification of vascular lineage-specific genes by transcriptional profiling of isolated blood vascular and lymphatic endothelial cells. Am. J. Pathol. 162 (2003) 575-586
31. Banziger-Tobler N.E., Halin C., Kajiya K., and Detmar M. Growth hormone promotes lymphangiogenesis. Am. J. Pathol. (2008)
32. Coyne C.B., Voelker T., Pichla S.L., and Bergelson J.M. The coxsackievirus and adenovirus receptor interacts with the multi-PDZ domain protein-1 (MUPP-1) within the tight junction. J. Biol. Chem. 279 (2004) 48079-48084
33. Detmar M., Tenorio S., Hettmannsperger U., Ruszczak Z., and Orfanos C.E. Cytokine regulation of proliferation and ICAM-1 expression of human dermal microvascular endothelial cells in vitro. J. Invest. Dermatol. 98 (1992) 147-153
34. Halin C., Fahrngruber H., Meingassner J.G., Bold G., Littlewood-Evans A., Stuetz A., and Detmar M. Inhibition of chronic and acute skin inflammation by treatment with a vascular endothelial growth factor receptor tyrosine kinase inhibitor. Am. J. Pathol. 173 (2008) 265-277
35. Kajiya K., Hirakawa S., Ma B., Drinnenberg I., and Detmar M. Hepatocyte growth factor promotes lymphatic vessel formation and function. EMBO J. 24 (2005) 2885-2895
36. Johnson L.A., Clasper S., Holt A.P., Lalor P.F., Baban D., and Jackson D.G. An inflammation-induced mechanism for leukocyte transmigration across lymphatic vessel endothelium. J. Exp. Med. 203 (2006) 2763-2777
37. Johnson L.A., Prevo R., Clasper S., and Jackson D.G. Inflammation-induced Uptake and degradation of the lymphatic endothelial hyaluronan receptor LYVE-1. J. Biol. Chem. 282 (2007) 33671-33680
38. Mirza M., Raschperger E., Philipson L., Pettersson R.F., and Sollerbrant K. The cell surface protein coxsackie- and adenovirus receptor (CAR) directly associates with the Ligand-of-Numb Protein-X2 (LNX2). Exp. Cell Res. 309 (2005) 110-120
39. Hong Y.K., Foreman K., Shin J.W., Hirakawa S., Curry C.L., Sage D.R., Libermann T., Dezube B.J., Fingeroth J.D., and Detmar M. Lymphatic reprogramming of blood vascular endothelium by Kaposi sarcoma-associated herpesvirus. Nat. Genet. 36 (2004) 683-685
40. Wick N., Saharinen P., Saharinen J., Gurnhofer E., Steiner C.W., Raab I., Stokic D., Giovanoli P., Buchsbaum S., Burchard A., Thurner S., Alitalo K., and Kerjaschki D. Transcriptomal comparison of human dermal lymphatic endothelial cells ex vivo and in vitro. Physiol. Genomics 28 (2007) 179-192
41. Amatschek S., Kriehuber E., Bauer W., Reininger B., Meraner P., Wolpl A., Schweifer N., Haslinger C., Stingl G., and Maurer D. Blood and lymphatic endothelial cell-specific differentiation programs are stringently controlled by the tissue environment. Blood 109 (2007) 4777-4785
42. Yamashita M., Ino A., Kawabata K., Sakurai F., and Mizuguchi H. Expression of coxsackie and adenovirus receptor reduces the lung metastatic potential of murine tumor cells. Int. J. Cancer 121 (2007) 1690-1696
43. Avraamides C.J., Garmy-Susini B., and Varner J.A. Integrins in angiogenesis and lymphangiogenesis. Nat. Rev. Cancer 8 (2008) 604-617
44. Shin J.W., Huggenberger R., and Detmar M. Transcriptional profiling of VEGF-A and VEGF-C target genes in lymphatic endothelium reveals endothelial-specific molecule-1 as a novel mediator of lymphangiogenesis. Blood (2008)
45. Randolph G.J., Angeli V., and Swartz M.A. Dendritic-cell trafficking to lymph nodes through lymphatic vessels. Nat. Rev. Immunol. 5 (2005) 617-628
46. Baluk P., Fuxe J., Hashizume H., Romano T., Lashnits E., Butz S., Vestweber D., Corada M., Molendini C., Dejana E., and McDonald D.M. Functionally specialized junctions between endothelial cells of lymphatic vessels. J. Exp. Med. 204 (2007) 2349-2362
47. Yang S., Graham J., Kahn J.W., Schwartz E.A., and Gerritsen M.E. Functional roles for PECAM-1 (CD31) and VE-cadherin (CD144) in tube assembly and lumen formation in three-dimensional collagen gels. Am. J. Pathol. 155 (1999) 887-895
48. Ishida T., Kundu R.K., Yang E., Hirata K., Ho Y.D., and Quertermous T. Targeted disruption of endothelial cell-selective adhesion molecule inhibits angiogenic processes in vitro and in vivo. J. Biol. Chem. 278 (2003) 34598-34604
49. Naik M.U., Mousa S.A., Parkos C.A., and Naik U.P. Signaling through JAM-1 and alphavbeta3 is required for the angiogenic action of bFGF: dissociation of the JAM-1 and alphavbeta3 complex. Blood 102 (2003) 2108-2114
50. Pfeiffer F., Kumar V., Butz S., Vestweber D., Imhof B.A., Stein J.V., and Engelhardt B. Distinct molecular composition of blood and lymphatic vascular endothelial cell junctions establishes specific functional barriers within the peripheral lymph node. Eur. J. Immunol. 38 (2008) 2142-2155